Evidence map›Paper›PMID 24993948›Full record

ArticleClinical and experimental nephrology2015

Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience.

Betul Tavil, Fehime Kara, Rezan Topaloglu, Selin Aytac, Sule Unal, Baris Kuskonmaz, Mualla Cetin, Nesrin Besbas, Fatma Gumruk

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Postoperative Intracardiac Thrombus in a Child with Nephrotic Syndrome.International medical case reports journal · 2022
    Article
  9. Article
  10. Article
  11. The non-immunosuppressive management of childhood nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2016
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Betul TavilPediatric Hematology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Fehime KaraPediatric Nephrology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Rezan TopalogluPediatric Nephrology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey. rezantopaloglu@hacettepe.edu.tr.
Selin AytacPediatric Hematology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Sule UnalPediatric Hematology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Baris KuskonmazPediatric Hematology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Mualla CetinPediatric Hematology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Nesrin BesbasPediatric Nephrology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Fatma GumrukPediatric Hematology Unit, Hacettepe Univesity Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey.
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to describe the incidence and contributory risk factors for thromboembolic complications in children with nephrotic syndrome (NS) and thrombosis.

methodsAmong 188 children with the diagnosis of NS (80 girls; mean age: 12.6 ± 5.4 years) followed up in our hospital for the last 5 years, 17 (9.0 %) children (16 boys) identified as having thromboembolic complications. All 17 children with NS and thrombosis were screened for laboratory risk factors for thrombosis. The diagnosis was confirmed by cranial magnetic resonance imaging, doppler ultrasonography, and echocardiography.

resultsAmong 17 children with thrombosis, 14 (82.3 %) were found to have focal segmental glomerulosclerosis (FSGS) as underlying pathology by renal biopsy. The mean age of the thrombotic children was 4.5 ± 3.2 years at the diagnosis of NS and that was 7.1 ± 4.9 years at the time of thrombosis. The mean time from NS diagnosis to the first thrombosis development was 2.6 ± 2.3 years. Thrombosis occurred during the first year of NS in 9/17 (52.9 %) children. Most of the children (88.2 %) had venous thrombosis. Among the screened risk factors, high factor VIII level (64.7 %) was the leading factor followed by decreased antithrombin III level (29.4 %). Furthermore, 4 children had central venous catheters and 2 had infection as clinical risk factors for thrombosis.

conclusionIn this case series, subtype of FSGS, active disease state of NS, central venous catheters, and some inherited and acquired thrombotic risk factors have been identified as contributory factors for the development of thrombosis in children with NS.

Indexed as

AdolescentAge of OnsetAntithrombin IIIAspirinBrain InfarctionCentral Venous CathetersChildChild, PreschoolFactor VIIIFemaleFibrinolytic AgentsFollow-Up StudiesGlomerulosclerosis, Focal SegmentalHeparin, Low-Molecular-WeightHumansIncidenceAntithrombin IIIAspirinFactor VIIIFibrinolytic AgentsHeparin, Low-Molecular-WeightMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanChildrenComplicationNephrotic syndromeThrombosis

Identifiers

PMID24993948
OpenAlexW1996935494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.